コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 NSVT episodes were characterized by QRS morphology, dura
2 NSVT occurred frequently during the acute and convalesce
3 NSVT was significantly associated with ICD-treated VT/VF
4 to 5,435) and increased with age (p < 0.01); NSVT was associated with greater left ventricular hypert
6 atients without (group 1) and with (group 2) NSVT were balanced for variables: age, etiology of heart
10 5), couplets (1.9 +/- 5 vs. 1.2 +/- 10), and NSVT runs (0.4 +/- 0.8 vs. 0.06 +/- 0.4) than non-DE pat
11 ure patients with ventricular arrhythmia and NSVT have a significantly increased risk of premature ca
12 e risk of paroxysmal atrial fibrillation and NSVT during sleep is markedly increased shortly after a
15 d quality of life in patients with NIDCM and NSVT treated with amiodarone or an ICD are not statistic
16 ection fraction < or =0.35, and asymptomatic NSVT were randomized to receive either amiodarone or an
17 h CAD and impaired LV function, asymptomatic NSVT identified in-hospital, compared with that identifi
19 ologic testing in patients with asymptomatic NSVT, CAD and LV dysfunction, eligible patients were enr
21 for NSVT episodes, with associations between NSVT- and ICD-treated ventricular arrhythmias examined.
22 There was a time-varying interaction between NSVT and cardiovascular death such that NSVT was signifi
23 treated with reperfusion and beta-blockers, NSVT is not an independent predictor of long-term mortal
24 , and most probably genetic channelopathies, NSVT carries prognostic significance, whereas its indepe
29 djusting other variables, especially for EF, NSVT was not an independent predictor of all-cause morta
30 d syncope (1.9 to 14.9) (p = 0.002); 1.9 for NSVT (0.7 to 5.0) (p = 0.18) and 2.9 for LVWT (1.1 to 7.
31 terrogated and ambulatory ECGs monitored for NSVT episodes, with associations between NSVT- and ICD-t
32 In acute myocardial infarction, in-hospital NSVT has an adverse prognostic significance when detecte
33 treated patients with in-hospital-identified NSVT and 11% and 21% for the out-of-hospital group (adju
35 d in 35% and 28% of the patients whose index NSVT occurred in-hospital and out-of-hospital, respectiv
36 ent for clinical variables, exercise-induced NSVT did not independently increase the risk of total mo
38 and coronary risk factors, exercise-induced NSVT was not significantly associated with total mortali
43 ss(i) (p < 0.001), and a higher frequency of NSVT (odds ratio 1.2; 95% confidence interval: 1.1 to 1.
44 variable demonstrated that the frequency of NSVT did not add significant information beyond the clin
45 ar arrhythmias, supporting the importance of NSVT in hypertrophic cardiomyopathy risk stratification.
46 fied time from presentation to occurrence of NSVT as the strongest predictor of mortality (P<0.0001).
47 the time from presentation to occurrence of NSVT increased, plateauing at approximately 24 hours wit
49 0.0001); DE was an independent predictor of NSVT (relative risk 7.3, 95% confidence interval 2.6 to
53 minute), shorter (</=7), or a single run of NSVT were not associated with ICD-treated ventricular ar
55 ), longer (>7 beats), and repetitive runs of NSVT were more highly predictive of ICD-treated VT/VF.
58 etermined the prevalence and significance of NSVT in patients with PVCs and heart failure and on vaso
61 Contrary to prevailing clinical opinion, NSVT that occurs in the setting of acute MI does have im
64 es not have an associated adverse prognosis, NSVT that occurs beyond the first several hours after pr
65 during exercise, and especially at recovery, NSVT indicates increased cardiovascular mortality within
69 nown predictors of mortality in SCD-HeFT, RR-NSVT was independently associated with appropriate ICD s
75 ate nonsustained ventricular tachycardia (RR-NSVT) during routine implantable cardioverter-defibrilla
76 The clinical evaluation of patients with RR-NSVT should include intensification of medical therapy,
77 with patients without RR-NSVT, those with RR-NSVT were less likely to be taking beta-blockers, statin
80 on, coronary artery disease, and symptomatic NSVT are at highest risk of receiving appropriate ICD sh
82 T-segment elevation acute coronary syndrome, NSVT occurring beyond 48 h after admission indicates an
84 on and nonsustained ventricular tachycardia (NSVT) as well as a predilection for sudden cardiac death
87 nduced nonsustained ventricular tachycardia (NSVT) in a large population of asymptomatic volunteers.
88 nce of nonsustained ventricular tachycardia (NSVT) in patients with hypertrophic cardiomyopathy is in
89 nce of nonsustained ventricular tachycardia (NSVT) in patients with premature ventricular contraction
91 which nonsustained ventricular tachycardia (NSVT) is discovered on the rate of inducibility of susta
92 ncy of nonsustained ventricular tachycardia (NSVT) was the most powerful predictor and remained a sig
93 s, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those wi
94 titive nonsustained ventricular tachycardia (NSVT), or 3) premature ventricular contractions (PVCs).
95 ables: nonsustained ventricular tachycardia (NSVT), syncope, exercise blood pressure response (BPR),
99 omatic nonsustained ventricular tachycardia (NSVT; HR, 9.1; 95% CI, 2.8-29.2; P=0.001) were associate
101 ifically, the currently accepted notion that NSVT that occurs within 48 hours of acute MI has no prog
102 ween NSVT and cardiovascular death such that NSVT was significantly associated with increased risk wi
104 fibrillation occurred more frequently in the NSVT group (9% versus 0% in the control group; P<0.001),
105 the clinical variables with and without the NSVT variable demonstrated that the frequency of NSVT di
106 ilar patients, the clinical setting in which NSVT is discovered should be taken into account when for
111 risk of cardiovascular death associated with NSVT was the greatest during the first 30 days after pre
112 tion that approximately 50% of patients with NSVT and approximately 5% of patients with PVCs have ind
113 s after presentation; however, patients with NSVT detected during the convalescent phase were also at
117 with NSVT and 6 of 74 patients (8%) without NSVT experienced ICD-treated ventricular tachycardia (VT
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。